Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Breast Cancer

  Free Subscription


06.07.2020

3 AJR Am J Roentgenol
2 Am J Surg
3 Ann Surg Oncol
3 BMC Cancer
4 Breast Cancer
2 Breast Cancer (Auckl)
2 Breast Cancer Res
13 Breast Cancer Res Treat
2 Breast J
3 Cancer
1 Cancer Epidemiol Biomarkers Prev
2 Cancer Lett
1 Cancer Res
1 Clin Breast Cancer
1 Eur Radiol
1 Exp Cell Res
1 Histopathology
2 J Biol Chem
3 J Clin Oncol
1 J Nucl Med
1 J Surg Oncol
1 Lancet
2 Lancet Oncol
1 N Engl J Med
1 Nat Rev Clin Oncol
1 Oncology (Williston Park)
4 PLoS One
1 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol

  1. BUTLER RS, Hooley RJ
    Screening Breast Ultrasound: Update After 10 Years of Breast Density Notification Laws.
    AJR Am J Roentgenol. 2020 Mar 17:1-12. doi: 10.2214/AJR.19.22275.
    PubMed         Abstract available

  2. MANGO VL, Sun M, Wynn RT, Ha R, et al
    Should We Ignore, Follow, or Biopsy? Impact of Artificial Intelligence Decision Support on Breast Ultrasound Lesion Assessment.
    AJR Am J Roentgenol. 2020 Apr 22:1-8. doi: 10.2214/AJR.19.21872.
    PubMed         Abstract available

  3. DODELZON K, Simon K, Dou E, Levy AD, et al
    Performance of 2D Synthetic Mammography Versus Digital Mammography in the Detection of Microcalcifications at Screening.
    AJR Am J Roentgenol. 2020 Apr 7:1-9. doi: 10.2214/AJR.19.21598.
    PubMed         Abstract available


    Am J Surg

  4. HUANG J, Chagpar A
    Effect of decision-making resources on satisfaction with decision to undergo contralateral prophylactic mastectomy (CPM).
    Am J Surg. 2020;219:1036-1038.
    PubMed         Abstract available

  5. WEN B, Mousadoust D, Warburton R, Pao JS, et al
    Phyllodes tumours of the breast: Outcomes and recurrence after excision.
    Am J Surg. 2020;219:790-794.
    PubMed         Abstract available


    Ann Surg Oncol

  6. WEISS A, King TA, Mittendorf EA
    The Landmark Series: Neoadjuvant Endocrine Therapy for Breast Cancer.
    Ann Surg Oncol. 2020 Jun 26. pii: 10.1245/s10434-020-08530.
    PubMed         Abstract available

  7. SUN J, Mathias BJ, Sun W, Fulp WJ, et al
    Is it Wise to Omit Sentinel Node Biopsy in Elderly Patients with Breast Cancer?
    Ann Surg Oncol. 2020 Jul 1. pii: 10.1245/s10434-020-08759.
    PubMed         Abstract available

  8. BAILEY CM, Selber J, Liu J, Lee CN, et al
    Current Practice and Perceptions Regarding Cost Communication in Breast Cancer Reconstruction: Survey Results of the American Society of Plastic Surgeons.
    Ann Surg Oncol. 2020 Jul 1. pii: 10.1245/s10434-020-08750.
    PubMed         Abstract available


    BMC Cancer

  9. TAKADA K, Kashiwagi S, Asano Y, Goto W, et al
    Prediction of lymph node metastasis by tumor-infiltrating lymphocytes in T1 breast cancer.
    BMC Cancer. 2020;20:598.
    PubMed         Abstract available

  10. MEZEI T, Hajdu M, Czigleczki G, Lotz G, et al
    Sterile, abscess-like cerebral lesion during trastuzumab therapy after HER2 status switch in a triple negative breast cancer patient: a case report and literature review.
    BMC Cancer. 2020;20:615.
    PubMed         Abstract available

  11. WANG J, Cai Y, Yu F, Ping Z, et al
    Body mass index increases the lymph node metastasis risk of breast cancer: a dose-response meta-analysis with 52904 subjects from 20 cohort studies.
    BMC Cancer. 2020;20:601.
    PubMed         Abstract available


    Breast Cancer

  12. CHONG F, Wang Y, Song M, Sun Q, et al
    Sedentary behavior and risk of breast cancer: a dose-response meta-analysis from prospective studies.
    Breast Cancer. 2020 Jun 30. pii: 10.1007/s12282-020-01126.
    PubMed         Abstract available

  13. BANDO H, Kataoka A, Tamaki K, Kobayashi M, et al
    Physician's knowledge, attitudes and practice pattern for breast cancer diagnosed during pregnancy: a survey among breast care specialists in Japan.
    Breast Cancer. 2020 Jun 26. pii: 10.1007/s12282-020-01118.
    PubMed         Abstract available

  14. TANAKA N, Hirano A, Hattori A, Ogura K, et al
    Effect of adjuvant chemotherapy in patients with ER + /HER2- breast cancer, assessed by propensity score matching: significance of nuclear grade and nodal status.
    Breast Cancer. 2020 Jun 26. pii: 10.1007/s12282-020-01125.
    PubMed         Abstract available

  15. TAJIRI W, Ijichi H, Takizawa K, Koi Y, et al
    The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer.
    Breast Cancer. 2020 Jun 29. pii: 10.1007/s12282-020-01130.
    PubMed         Abstract available


    Breast Cancer (Auckl)

  16. MISHRA A, Bonello M, Byron A, Langdon SP, et al
    Evaluation of Gene Expression Data From Cybrids and Tumours Highlights Elevated NDRG1-Driven Proliferation in Triple-Negative Breast Cancer.
    Breast Cancer (Auckl). 2020;14:1178223420934447.
    PubMed         Abstract available

  17. ALSHARI O, Aleshawi A, Al Sharie AH, Msameh A, et al
    The Effect of Nail Lacquer on Taxane-Induced Nail Changes in Women With Breast Cancer.
    Breast Cancer (Auckl). 2020;14:1178223420929702.
    PubMed         Abstract available


    Breast Cancer Res

  18. BYERLY JH, Port ER, Irie HY
    PRKCQ inhibition enhances chemosensitivity of triple-negative breast cancer by regulating Bim.
    Breast Cancer Res. 2020;22:72.
    PubMed         Abstract available

  19. TERKELSEN T, Russo F, Gromov P, Haakensen VD, et al
    Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
    Breast Cancer Res. 2020;22:73.
    PubMed         Abstract available


    Breast Cancer Res Treat

  20. YAO J, Liu Y, Cheng J
    Standardize the management procedures for breast cancer patients during the outbreak of COVID-19 in Wuhan, China.
    Breast Cancer Res Treat. 2020 Jun 27. pii: 10.1007/s10549-020-05743.
    PubMed         Abstract available

  21. CHEN FM, Huang LJ, Ou-Yang F, Kan JY, et al
    Activation of mitochondrial unfolded protein response is associated with Her2-overexpression breast cancer.
    Breast Cancer Res Treat. 2020 Jun 29. pii: 10.1007/s10549-020-05729.
    PubMed         Abstract available

  22. YANG X, Zhao L, Pei J, Wang Z, et al
    CELF6 modulates triple-negative breast cancer progression by regulating the stability of FBP1 mRNA.
    Breast Cancer Res Treat. 2020 Jun 29. pii: 10.1007/s10549-020-05753.
    PubMed         Abstract available

  23. KHALEFA HG, Shawki MA, Aboelhassan R, El Wakeel LM, et al
    Evaluation of the effect of N-acetylcysteine on the prevention and amelioration of paclitaxel-induced peripheral neuropathy in breast cancer patients: a randomized controlled study.
    Breast Cancer Res Treat. 2020 Jun 29. pii: 10.1007/s10549-020-05762.
    PubMed         Abstract available

  24. HACKSHAW MD, Danysh HE, Singh J, Ritchey ME, et al
    Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancer.
    Breast Cancer Res Treat. 2020 Jun 26. pii: 10.1007/s10549-020-05754.
    PubMed         Abstract available

  25. GUO D, Hendryx M, Liang X, Manson JE, et al
    Association between selenium intake and breast cancer risk: results from the Women's Health Initiative.
    Breast Cancer Res Treat. 2020 Jun 30. pii: 10.1007/s10549-020-05764.
    PubMed         Abstract available

  26. WANG DG, Barrios DM, Blinder VS, Bromberg JF, et al
    Dermatologic adverse events related to the PI3Kalpha inhibitor alpelisib (BYL719) in patients with breast cancer.
    Breast Cancer Res Treat. 2020 Jun 29. pii: 10.1007/s10549-020-05726.
    PubMed         Abstract available

  27. WALTER V, Fischer C, Deutsch TM, Ersing C, et al
    Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer.
    Breast Cancer Res Treat. 2020 Jul 1. pii: 10.1007/s10549-020-05746.
    PubMed         Abstract available

  28. SPECHT M, Sobti N, Rosado N, Tomczyk E, et al
    High-Efficiency Same-Day Approach to Breast Reconstruction During the COVID-19 Crisis.
    Breast Cancer Res Treat. 2020;182:679-688.
    PubMed         Abstract available

  29. CAVAZZA M, Banks H, Ercolanoni M, Cukaj G, et al
    Factors influencing adherence to adjuvant endocrine therapy in breast cancer-treated women: using real-world data to inform a switch from acute to chronic disease management.
    Breast Cancer Res Treat. 2020 Jun 26. pii: 10.1007/s10549-020-05748.
    PubMed         Abstract available

  30. PERACHINO M, Poggio F, Lambertini M
    Call for assessing treatment-induced gonadotoxicity of platinum-based chemotherapy in early breast cancer.
    Breast Cancer Res Treat. 2020 Jun 28. pii: 10.1007/s10549-020-05767.
    PubMed        

  31. ACCORDINO MK, Wright JD, Buono D, Lin A, et al
    Incidence and Predictors of Diabetes Mellitus after a Diagnosis of Early-Stage Breast Cancer in the Elderly Using Real-World Data.
    Breast Cancer Res Treat. 2020 Jun 26. pii: 10.1007/s10549-020-05756.
    PubMed         Abstract available

  32. DONAHUE PMC, Crescenzi R, Lee C, Garza M, et al
    Magnetic resonance imaging and bioimpedance evaluation of lymphatic abnormalities in patients with breast cancer treatment-related lymphedema.
    Breast Cancer Res Treat. 2020 Jun 29. pii: 10.1007/s10549-020-05765.
    PubMed         Abstract available


    Breast J

  33. NGASERIN S, Chua HW, Chew MH, Tan BK, et al
    A tripartite approach can seek to optimize breast cancer management during a pandemic - Real-Time experience of a developing breast oncology unit in Singapore.
    Breast J. 2020 Jul 1. doi: 10.1111/tbj.13961.
    PubMed        

  34. CASELLA D, Fusario D, Cassetti D, Miccoli S, et al
    The patient's pathway for breast cancer in the COVID-19 era: An Italian single-center experience.
    Breast J. 2020 Jun 28. doi: 10.1111/tbj.13958.
    PubMed         Abstract available


    Cancer

  35. GUO F, Scholl M, Fuchs EL, Berenson AB, et al
    BRCA testing in unaffected young women in the United States, 2006-2017.
    Cancer. 2020;126:337-343.
    PubMed         Abstract available

  36. SONG Y, Barry WT, Seah DS, Tung NM, et al
    Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers.
    Cancer. 2020;126:271-280.
    PubMed         Abstract available

  37. SHEPPARD VB, Dash C, Nomura S, Sutton AL, et al
    Physical activity, health-related quality of life, and adjuvant endocrine therapy-related symptoms in women with hormone receptor-positive breast cancer.
    Cancer. 2020 Jul 2. doi: 10.1002/cncr.33054.
    PubMed         Abstract available


    Cancer Epidemiol Biomarkers Prev

  38. LANGE M, Hardy-Leger I, Licaj I, Pistilli B, et al
    Cognitive impairment in breast cancer patients before surgery: results from a CANTO cohort subgroup.
    Cancer Epidemiol Biomarkers Prev. 2020 Jul 1. pii: 1055-9965.EPI-20-0346.
    PubMed         Abstract available


    Cancer Lett

  39. WU J, Yan J, Fang P, Zhou HB, et al
    Three-dimensional oxabicycloheptene sulfonate targets the homologous recombination and repair programmes through estrogen receptor alpha antagonism.
    Cancer Lett. 2020;469:78-88.
    PubMed         Abstract available

  40. NAN X, Wang J, Cheng H, Yin Z, et al
    Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways.
    Cancer Lett. 2020;469:195-206.
    PubMed         Abstract available


    Cancer Res

  41. BANIK D, Noonepalle S, Hadley M, Palmer E, et al
    HDAC6 plays a non-canonical role in the regulation of anti-tumor immune responses, dissemination, and invasiveness of breast cancer.
    Cancer Res. 2020 Jun 30. pii: 0008-5472.CAN-19-3738.
    PubMed         Abstract available


    Clin Breast Cancer

  42. CO M, Kwong A
    Breast Cancer Rate and Mortality in Female Flight Attendants: A Systematic Review and Pooled Analysis.
    Clin Breast Cancer. 2020 May 12. pii: S1526-8209(20)30095.
    PubMed         Abstract available


    Eur Radiol

  43. MAO N, Yin P, Li Q, Wang Q, et al
    Radiomics nomogram of contrast-enhanced spectral mammography for prediction of axillary lymph node metastasis in breast cancer: a multicenter study.
    Eur Radiol. 2020 Jun 30. pii: 10.1007/s00330-020-07016.
    PubMed         Abstract available


    Exp Cell Res

  44. LIU JH, Chen C, Li ZY, Zou ZM, et al
    The MyD88 inhibitor TJ-M2010-2 suppresses proliferation, migration and invasion of breast cancer cells by regulating MyD88/GSK-3beta and MyD88/NF-kappaB signalling pathways.
    Exp Cell Res. 2020 Jun 28:112157. doi: 10.1016/j.yexcr.2020.112157.
    PubMed         Abstract available


    Histopathology

  45. DOWNES MR, Slodkowska E, Katabi N, Jungbluth AA, et al
    Interobserver and Intraobserver agreement of PD-L1 scoring in Head and Neck Squamous Cell Carcinoma (HSCC), Urothelial Carcinoma (UC), and Breast Carcinoma (BC).
    Histopathology. 2019 Jun 27. doi: 10.1111/his.13946.
    PubMed         Abstract available


    J Biol Chem


  46. Expression of Concern: Bone marrow stromal cell-derived growth inhibitor inhibits growth and migration of breast cancer cells via induction of cell cycle arrest and apoptosis.
    J Biol Chem. 2020;295:8876.
    PubMed        


  47. Expression of Concern: Blockade of Fas signaling in breast cancer cells suppresses tumor growth and metastasis via disruption of Fas signaling-initiated cancer-related inflammation.
    J Biol Chem. 2020;295:8886.
    PubMed        


    J Clin Oncol

  48. CHLEBOWSKI RT, Aragaki AK, Prentice RL
    Dietary Moderation and Deaths From Breast Cancer.
    J Clin Oncol. 2020 Jul 2:JCO2001218. doi: 10.1200/JCO.20.01218.
    PubMed        

  49. DESMEDT C, Fornili M, Clatot F, Demicheli R, et al
    Differential Benefit of Adjuvant Docetaxel-Based Chemotherapy in Patients With Early Breast Cancer According to Baseline Body Mass Index.
    J Clin Oncol. 2020 Jul 2:JCO1901771. doi: 10.1200/JCO.19.01771.
    PubMed         Abstract available

  50. RAYSON D
    Camouflage.
    J Clin Oncol. 2020;38:281-282.
    PubMed        


    J Nucl Med

  51. PETERSON LM, Kurland BF, Yan F, Novakova-Jiresova A, et al
    (18)F-Fluoroestradiol ((18)F-FES)-PET imaging in a Phase II trial of vorinostat to restore endocrine sensitivity in ER+/HER2- metastatic breast cancer.
    J Nucl Med. 2020 Jun 26. pii: jnumed.120.244459. doi: 10.2967/jnumed.120.244459.
    PubMed         Abstract available


    J Surg Oncol

  52. BOLAND MR, Ryan EJ, Nugent T, Gilroy D, et al
    Impact of progesterone receptor status on response to neoadjuvant chemotherapy in estrogen receptor-positive breast cancer patients.
    J Surg Oncol. 2020 Jul 1. doi: 10.1002/jso.26096.
    PubMed         Abstract available


    Lancet

  53. MURRAY BRUNT A, Haviland JS, Wheatley DA, Sydenham MA, et al
    Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.
    Lancet. 2020;395:1613-1626.
    PubMed         Abstract available


    Lancet Oncol

  54. BENSON JR
    Quality of life after breast-conserving surgery for women with non-low-risk ductal carcinoma in situ.
    Lancet Oncol. 2020;21:612-614.
    PubMed        

  55. MALEKPOUR M, Widger J
    Radiation-induced angiosarcoma in a patient with breast cancer.
    Lancet Oncol. 2020;21:e369.
    PubMed        


    N Engl J Med

  56. SPRING LM, Specht MC, Jimenez RB, Isakoff SJ, et al
    Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 Pandemic.
    N Engl J Med. 2020 Jul 1. doi: 10.1056/NEJMcpc2002422.
    PubMed        


    Nat Rev Clin Oncol

  57. PASHAYAN N, Antoniou AC, Ivanus U, Esserman LJ, et al
    Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement.
    Nat Rev Clin Oncol. 2020 Jun 29. pii: 10.1038/s41571-020-0412.
    PubMed         Abstract available


    Oncology (Williston Park)


  58. Assessing the Impact of TAILORx on Breast Cancer Management.
    Oncology (Williston Park). 2020;34:224-226.
    PubMed         Abstract available


    PLoS One

  59. TANAKA M, Hsuan C, Oeki M, Shen W, et al
    Identification of characteristic compounds of moderate volatility in breast cancer cell lines.
    PLoS One. 2020;15:e0235442.
    PubMed         Abstract available

  60. THURING J, Kuhl CK, Barabasch A, Hitpass L, et al
    Signal changes in T2-weighted MRI of liver metastases under bevacizumab-A practical imaging biomarker?
    PLoS One. 2020;15:e0230553.
    PubMed         Abstract available

  61. RAINES MILENKOV A, Felini M, Baker E, Acharya R, et al
    Uptake of cancer screenings among a multiethnic refugee population in North Texas, 2014-2018.
    PLoS One. 2020;15:e0230675.
    PubMed         Abstract available

  62. HAILU HE, Mondul AM, Rozek LS, Geleta T, et al
    Descriptive Epidemiology of breast and gynecological cancers among patients attending Saint Paul's Hospital Millennium Medical College, Ethiopia.
    PLoS One. 2020;15:e0230625.
    PubMed         Abstract available


    Radiother Oncol

  63. MULLIEZ T, Barbe K, de Ridder M
    Estimating lung cancer and cardiovascular mortality in female breast cancer patients receiving radiotherapy.
    Radiother Oncol. 2020 Mar 26. pii: S0167-8140(20)30153.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: